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Plectranthus barbatus is a medicinal plant used to treat a wide range of disorders including seizure. However, the anticonvulsant
activity of this plant has not been studied in depth. We therefore sought to evaluate the anticonvulsantactivity of a hydroalcoholic
extract of P. barbatus leaves on seizures induced by strychnine sulphate (2.0mg/kg) and pilocarpine (600mg/kg) in mice. The
extract was administered orally at 1, 10, 30, and 100mg/kg. We report that the P. barbatus extract had marked anticonvulsant
activity against strychnine-induced convulsions, but was quite ineﬀective against pilocarpine-induced convulsions. Further
experiments will be required to identify the active molecules(s) and their mechanism(s) of action.
1.Introduction
Plectranthus barbatus Andr. is a perennial shrub that is
thought to have originated in Africa and is used as a
medicinal plant to treat a wide range of disorders. The
plant is also known by the synonyms Plectranthus forskohlii
Briq, Plectranthus forskalaei Willd., Plectranthus kilimand-
schari (G¨ urke) H.L. Maass., Plectranthus grandis (Cramer)
R.H. Willemse, Coleus forskohlii Briq., Coleus kilimandschari
G¨ urke ex Engl., Coleus coerulescens G¨ urke, and Coleus
barbatus (Andr.) Benth[1].The medicinal usesofP. barbatus
include digestive, respiratory, circulatory, nervous disorders
[1] and infections [2] and has been reported to have
abortifacient, contraceptive [3], and antipain [4]p r o p e r t i e s .
The plant is also used to treat gastritis and intestinal spasms
[5], nausea [6], stomach ache, and as a purgative [7]. Uses in
respiratory disorders include the relief of colds [8], cough,
[4] and bronchitis [9], and in the circulatory system uses
include myalgia, angina, and hypertension [4].
P. barbatus is also used for the treatment of epilepsy and
convulsions [10]; however, only limited data are available
concerning the anticonvulsant activity of this plant. The
present work was undertaken to evaluate the anticonvulsant
activity of an extract of Plectranthus barbatus leaves.
2.Methods
2.1. Plant Extract Preparation. Fresh leaves of cultivated
Plectranthus barbatus were obtained from the Medicinal
and Toxic Plants Garden, Sector of Seedlings Produc-
tion, Universidade Federal Rural do Semi-´ Arido—UFERSA,
Mossor´ o, RN, Brazil. A reference specimen is deposited in
the Prisco Bezerra Herbarium at the Universidade Federal
do Cear´ a, Fortaleza, CE, Brazil, under number 24408. Leaves
were air-dried at 35◦C, pulverized, and the powder was
extracted with ethanol:water (20:80), ﬁltered, and dried
by evaporation. The dry extract was dissolved in distillated
water at concentration of 50mg dried P. barbatus solids per
ml.
2.2. Animals. Swiss albino male mice, weighing between
25 to 30g, two months old, were kept under controlled
conditions (21–25◦C on a 12h:12h light:dark cycle).
Animals were maintained on a standard mouse diet; before
the experiments they were fasted overnight with water ad
libitum.
Ethical procedures were based on the Brazilian law 6638
(May 8, 1979) “Normas para Pr´ atica Did´ atico-Cient´ ıﬁca
da Vivissecc ¸˜ ao de Animais” and “Ethical Principles for2 Evidence-Based Complementary and Alternative Medicine
Table 1: Anticonvulsant eﬀect of Plecthranthus barbatus leaf extracts on strychnine-induced seizures in mice.
Dose (mg/kg) p.o. Time to seizure onset (s) Death latency (s) Death rate (%)
0 (control) 217 ± 23.9 282.0 ± 46.7 100
1 461.3 ± 68.1∗ 518.8 ± 48.6∗ 100
10 236.4 ± 51.3 353.0 ± 46.7 100
30 317.4 ± 45.4 452.3 ± 52.6 87.5
100 no seizures no seizures 0
∗P<. 05, compared to control (ANOVA followed by Dunnett’s multiple comparisons test).
Table 2: Anticonvulsant eﬀects of Plecthranthus barbatus extract on pilocarpine-induced seizures in mice.
Dose (mg/kg) p.o. Time to seizure onset (s) Death latency (s) Death rate (%)
0 (control) 117.1 ± 14.8 194.7 ± 19.9 100
1 300.9 ± 53.3∗ 364.5 ± 59.4∗ 100
10 373.9 ± 18.7∗ 468.1 ± 39.6∗ 100
30 276.4 ± 20.6∗ 317.1 ± 26.9 100
100 261.0 ± 29.1∗ 334.0 ± 25.2∗ 100
∗P<. 05, signiﬁcant diﬀerence compared to control (ANOVA followed by Dunnett’s multiple comparisons test).
Use of Experimental Animals” from Col´ egio Brasileiro de
Experimentac ¸˜ ao Animal (COBEA), Brazil, which are in
accordance with the “European Convention for the Protec-
tion of Vertebrate Animals used for Experimental and Other
Scientiﬁc Purposes” (Strasbourg, March 18, 1986).
2.3. Evaluation of Anticonvulsant Activity. For each seizure-
inducing drug tested, 40 mice were divided into ﬁve groups
ofeight animals; P. barbatus extract was administered by oral
gavageatdosesof0,1,10,30,and 100mg/kg.Thirty minutes
after administration, each mouse was injected intraperi-
toneally with strychnine (2.0mg/kg) or with pilocarpine
(600mg/kg). The doses of used drugs were deﬁned in a pilot
study. The latency to ﬁrst convulsion and the latency and
percentage mortality were recorded for a period of 30 min.
Animals surviving more than 30 min were considered to be
protected.
2.4. Statistical Analysis. Results are expressed as means ±
standard error of the mean (SEM). Comparisons between
the averages of series of values were performed by ANOVA
followed by Dunnett’s multiple comparisons test. Data
analysis employed Graphpad INSTAT version 2.0 software;
statistical signiﬁcance was set at P<. 05.
3.Results
P. barbatus e x t r a c ta td o s e so f1a n d1 0 0m g / k gs i g n i ﬁ c a n t l y
(P<. 05) delayed the onset of strychnine-induced seizures
(Table 1) .A tad o s eo f1m g / k g ,t h e r ew a sas i g n i ﬁ c a n t( P<
.05) increase in the latency to death, but the extract failed
to protect the animals against drug-induced death. At a
dose of 10mg/kg, there was no signiﬁcant diﬀerence in time
before onset of seizure or death latency. However, P. barbatus
extract at dose of 30mg/kg protected 12.5% (1/8) of treated
animals; although time to seizure onset and latency to death
were increased byextract administration the diﬀerencefailed
to achieve statistical signiﬁcance (P>. 05). At 100mg/kg,
all treated animals (8/8) were now protected against drug-
induced death (P<. 0001).
For pilocarpine-induced seizures, all P. barbatus extract
doses (1, 10, 30, and 100mg/kg) signiﬁcantly (P<. 05)
delayed seizure onset, and doses of 1, 10, and 100mg/kg
signiﬁcantly (P<. 05) increased the latency to death.
However, no signiﬁcant retardation of deathlatency at a dose
of 30mg/kg was seen compared to the control group, and no
dose protected animals from convulsions or death (Table 2).
4.Discussion
We report that a hydroalcoholic extract of leaves of Plec-
tranthus barbatus exerts anticonvulsant eﬀects against both
strychnine- and pilocarpine-induced seizures. All tested
doses of P. barbatus extract retarded pilocarpine-induced
seizures but failed to protect against death. By contrast, no
seizure activity and no death were observed in strychnine-
treated animals pretreated with the highest tested dose of
P. barbatus extract (100mg/kg).
The mechanism underlying strychnine-induced seizures
is thought to involve direct antagonism of strychnine-
sensitive glycine receptors not only in higher brain areas but
also in the spinal cord and brainstem, thereby abrogating
spinal reﬂexes and causing motor disturbance, increased
muscle tone, hyperactivity of sensory, visual and acoustic
perception,tonicconvulsions, and deaththroughrespiratory
or spinal paralysis or by cardiac arrest [11]. Our results
demonstrate that strychnine-induced seizures are partly
suppressed by P. barbatus treatment.
Pilocarpine is a nonspeciﬁc muscarinic acetylcholine
receptor agonist; it has been suggested that cerebral struc-
tures with a high density of muscarinic receptors are likely to
representthesitesoforiginofacutepilocarpineseizures[12].
Pilocarpine administration to rodents leads to repetitive
limbic seizures and status epilepticus, replicating several
features of human temporal lobe epilepsy [13]. It was
previously suggested that extracts of P. amboinicus mightEvidence-Based Complementary and Alternative Medicine 3
antagonize cholinergic action at muscarinic receptors [14].
On the other hand, P. barbatus extracts were previously
reported to inhibit acetylcholinesterase activity [15]. In the
present work, the administration of P. barbatus extracts
failed to inhibit pilocarpine-induced seizures, even though
it retarded the onset of the seizures. Thus, it appears likely
that P. barbatus extract presented slight antagonist action in
the muscarinic acetylcholine receptors.
Phytochemical studies on P. barbatus have revealed nu-
merous bioactive compounds: notably diterpenoids includ-
ing forskolin [16], plectranthone J, plectrin, (16S)-coleon
E, coleon F, (16R)-plectrinone A, plectrinone B [17],
cyclobarbatusin, barbatusin, and 7β-acetyl-12-desacetoxi-
cyclobarbatusin [18]. Of these, forskolin is a promising
candidate for the anticonvulsant activity of P. barbatus
because this molecule was shown to suppress seizures
inducedbypentylenetetrazol [19].Forskolinactivatesadeny-
late cyclase and increases intracellular cAMP levels. It was
previously reported that forskolin can elicit membrane
depolarization in medium spiny neurons of the mouse
nucleus accumbens; this was mediated by cAMP stimulation
of inward rectiﬁer K+ currents [20]. Forskolin increases the
amplitude of glycinergic miniature inhibitory postsynaptic
currents in the presence of low concentrations of extracel-
lular glycine in isolated rat substantia gelatinosa neurons
[21].
In addition to direct eﬀects on ion channels, forskolin
treatment is likely to exert neuroprotective eﬀects by
increasing cellular levels of neurotrophin-3 (NT-3) [22], a
member of the neurotrophin family of neurotrophic factors
that support cell survival, axonal growth, and neuronal
plasticity [23, 24]. Brain injury decreases NT-3 synthesis
in the hippocampus [25], whereas NT-3 supplementation
can protect neurons against excitotoxic insult [26]. Seizures
induced by kainic acid [27] or pilocarpine [28]i n j e c t i o n
decreased NT-3 expression in the brain of mice, whereas
intraventricular infusion of NT-3 in rats inhibited kindling
epileptogenesis, mossy ﬁber sprouting, and increases in hilar
area [29], arguing that NT-3 upregulation by forskolin is
likely to inhibit seizure development and seizure-related
synaptic reorganization.
5.Conclusion
In conclusion, P. barbatus extract was found to have marked
anticonvulsant activity against strychnine-induced convul-
sions, but was quite ineﬀective against pilocarpine-induced
convulsions. Although forskolin is a promising candidate
molecule for the anticonvulsant activity of P. barbatus
extracts, it is possible that the bioactivity is mediated by a
combination oftwo ormore molecules. Furtherexperiments
will be required to identify the active molecules(s) and their
mechanism(s) of action.
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